13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details


Clinical trials : 3,342 Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03052595
(ClinicalTrials.gov)
February 1, 201710/2/2017Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR ResistanceMultiple Sclerosis: The Role of Mitochondrial Dysfunction in Insulin ResistanceMultiple Sclerosis;Mitochondrial AlterationDiagnostic Test: Oral glucose tolerance test;Diagnostic Test: Testing of autonomous nervous system function;Diagnostic Test: Stroop testSlovak Academy of SciencesComenius UniversityRecruiting18 Years45 YearsAll70Slovakia
2NCT00062972
(ClinicalTrials.gov)
September 199918/6/2003Improving Memory in Patients With Multiple SclerosisInterventions to Improve Memory in Patients With Multiple SclerosisMultiple SclerosisDrug: donepezil;Drug: glucoseEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)U.S. Department of EducationWithdrawn18 Years56 YearsAll0Phase 3United States